Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Feb 20, 2025

SELL
$57.89 - $64.73 $280,708 - $313,875
-4,849 Closed
0 $0
Q2 2023

Feb 20, 2025

BUY
$63.71 - $70.74 $308,929 - $343,018
4,849 New
4,849 $310 Million
Q1 2023

Feb 20, 2025

SELL
$65.71 - $74.53 $213,097 - $241,700
-3,243 Reduced 37.34%
5,441 $377 Million
Q4 2022

Feb 20, 2025

SELL
$68.48 - $81.09 $676,924 - $801,574
-9,885 Reduced 53.23%
8,684 $625 Million
Q3 2022

Feb 20, 2025

SELL
$0.13 - $76.84 $376 - $222,759
-2,899 Reduced 13.5%
18,569 $1.32 Billion
Q2 2022

Feb 20, 2025

BUY
$72.62 - $79.98 $670,573 - $738,535
9,234 Added 75.48%
21,468 $1.65 Billion
Q1 2022

Feb 20, 2025

BUY
$61.48 - $73.72 $532,908 - $639,004
8,668 Added 243.07%
12,234 $893 Million
Q4 2021

Feb 20, 2025

SELL
$53.63 - $62.52 $72,615 - $84,652
-1,354 Reduced 27.52%
3,566 $222 Million
Q3 2021

Feb 20, 2025

SELL
$59.17 - $69.31 $17,455 - $20,446
-295 Reduced 5.66%
4,920 $291,000
Q2 2021

Feb 20, 2025

SELL
$61.91 - $67.42 $108,404 - $118,052
-1,751 Reduced 25.14%
5,215 $349 Million
Q1 2021

Feb 20, 2025

SELL
$59.34 - $66.74 $3,560 - $4,004
-60 Reduced 0.85%
6,966 $440 Million
Q4 2020

Feb 20, 2025

SELL
$57.74 - $65.43 $231,190 - $261,981
-4,004 Reduced 36.3%
7,026 $436 Million
Q3 2020

Feb 20, 2025

SELL
$57.43 - $63.64 $46,690 - $51,739
-813 Reduced 6.86%
11,030 $665 Million
Q2 2020

Feb 20, 2025

BUY
$54.82 - $64.09 $29,273 - $34,224
534 Added 4.72%
11,843 $696 Million
Q1 2020

Feb 20, 2025

BUY
$46.4 - $67.43 $524,737 - $762,565
11,309 New
11,309 $631 Million
Q4 2019

Feb 20, 2025

BUY
$49.21 - $64.19 $225,332 - $293,926
4,579 Added 91.67%
9,574 $615 Million
Q3 2019

Feb 20, 2025

SELL
$42.77 - $50.71 $39,733 - $47,109
-929 Reduced 15.68%
4,995 $253 Million
Q2 2019

Feb 20, 2025

SELL
$44.62 - $49.34 $33,911 - $37,498
-760 Reduced 11.37%
5,924 $269 Million
Q1 2019

Feb 20, 2025

BUY
$45.12 - $53.8 $78,689 - $93,827
1,744 Added 35.3%
6,684 $319 Million
Q4 2018

Feb 20, 2025

BUY
$48.76 - $63.23 $240,874 - $312,356
4,940 New
4,940 $257 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $119B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Clare Market Investments LLC Portfolio

Follow Clare Market Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clare Market Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clare Market Investments LLC with notifications on news.